<DOC>
	<DOCNO>NCT02707484</DOCNO>
	<brief_summary>Gastrointestinal vascular malformation ( GIVM ) , important cause acute chronic gastrointestinal bleeding , currently lack effective treatment . The investigator ' previous study first confirm thalidomide treatment GIVM bleed safe effective . This prospective multi-center randomize controlled clinical trial intend investigate efficacy thalidomide recurrent small intestinal hemorrhage due GIVM .</brief_summary>
	<brief_title>Efficiency Thalidomide Recurrent Small Intestinal Bleeding Due Gastrointestinal Vascular Malformation</brief_title>
	<detailed_description>This multi-institutional clinical trial investigates efficacy thalidomide recurrent small intestinal hemorrhage due GIVM . Patients annual average bleed 4 time lesion locate small intestine suitable endoscopic therapy randomly assign receive A ( 25mg , Thalidomide，qid ) , B ( 25mg , Thalidomide , bid &amp; placebo bid ) placebo ( deferred treatment group ) 4 month . The primary endpoint difference yearly bleed Episodes , follow difference Blood Transfusions , Total Transfused Red Cell Requirements , Bleeding Duration , yearly mean Hemoglobin ( Hb ) level , hospitalization iron requirement . After one year follow-up , treatment 100mg thalidomide might pay supplementary therapy non-responders necessary . This study do 10 center China .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Vascular Malformations</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>The patient sign inform consent inform specific trial plan ; The patient China nationality ; The patient age 18 70 year old , male female ; Patients must agree follow acceptable birth control physical intrauterine contraceptive ring use condom . Female potential pregnancy need negative serum urine pregnancy test prior treatment . The intestinal vascular lesion find capsule endoscopy , / balloon assist enteroscopy ; OR patient present persistent recurrent bleeding , bleed lesion unable located initial negative result endoscopic evaluation upper GI endoscopy , colonoscopy CTE ; The patient present persistent recurrent bleeding ( &gt; =4 time yearly ) ; Hb level decrease 10 % low baseline； The patient willing comply instruction ability complete study research program . patient associated varicosity due cirrhosis liver ; Or patient uncontrolled hypertension , uncontrolled hyperglycemia , severe disease ; patient history severe peripheral neuropathy , seizure , rheumatoid immune disease , thromboembolic disease ; patient indication constantly use nonsteroidal antiinflammatory drug , anticoagulant antiplatelet acetyl salicylic acid preparation , ginkgo , Echinacea , Chinese herbal medicine composition , antiangiogenesis drug ; patient malignant severe heart disease ( uncontrolled angina and/or myocardial infarction , congestive heart failure within 3 month recruit , etc . ) , lung disease ( respiratory failure ) , kidney ( Cr , BUN 2 time normal ceiling ) , pancreatic , liver disease ( severe liver function damage 2 time normal ALT , AST , TBIL cap ) diseases researcher evaluate affect judgment treatment ; sustain WBC &lt; 3.5 * 109 / L ; previously small intestinal bowel resection surgery ; patient know suspected allergic ingredient thalidomide ; serious lifethreatening gastrointestinal bleeding require immediate surgical treatment ; patient use study drug within 30 day recruit ; alcohol and/or drug abuse , addiction rely ) doctor determine compliance claim ; patient recruit clinical research within 6 month ; personnel relate study ; patient legal behavior ability selfknowledge ; Or patient refuse group .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Gastrointestinal vascular malformation</keyword>
	<keyword>thalidomide</keyword>
	<keyword>Small intestinal bleeding</keyword>
</DOC>